Canada Research Chair in the Molecular Imaging of Diabetes
Globally, type 2 diabetes (T2D) causes one out of five or six deaths in middle-aged women and men, respectively. Clinical management focuses mainly on blood glucose level control. However, fat metabolism disorders involving white and brown adipose tissues (WAT and BAT) and the heart occur earlier, playing a crucial role in T2D and its complications.
Main Objective of the Research Program
During the first 7-year tenure of the Canada Research Chair in Molecular Imaging of Diabetes, Professor André Carpentier and his research team pursued the development of innovative molecular imaging and tracer methods to unravel the complex interplay between adipose tissue metabolic dysfunction and increased fatty acid channeling to lean organs.
This second research program will establish adipose tissue metabolic dysfunction as a target for the treatment of diabetes and its complications and will provide new methods to identify and monitor these complex pathogenic mechanisms.
Chairholder
André Carpentier
Profile
André Carpentier is a professor in the Department of Medicine of the Faculty of Medicine and Health Sciences.
He is also the scientific director of the Centre de recherche du CHUS (CRCHUS), and endocrinologist at the CIUSSS de l’Estrie - CHUS.
Fields of research and expertise
Diabetes, Fatty acid metabolism, Molecular Imaging, Positron Emission Tomography, Stable Isotopic Tracers, Adipose Tissues, Type 2 Diabetes, Thermogenesis, Obesity, Adipose Tissue Metabolic Function
Research Relevance
Development of new diagnostic and therapeutic tools for type 2 diabetes.
Funding
- Canada Research Chairs Program
- Canadian Institutes of Health Research
Additional Information
- Tier 1 Chair - 2018-01-10
- Renewed: 2025-10-01